Health Experts Evaluate Safety of BRAF Inhibitors in CNS Tumors Recent discussions led by Patrick Y. Wen, MD, and Karisa C. Schreck, MD, PhD, have highlighted safety considerations related to the use of BRAF... Editorial1 hour ago